In our media library you will find publications, videos and picture material about the CARL System, which document the current state of development and the performance of our products.
© Resuscitec 2021. The image and media material is protected by copyright. Use exclusively for editorial purposes and reporting, provided the author is acknowledged. The material may not be modified.
Current publication on the application of the CARL System at the Regensburg University Hospital
An article was published in the journal Perfusion in November 2022 presenting data from the first ten patients suffering from an out-of-hospital cardiovascular arrest who were treated by using the CARL System in Regensburg.
New press release
Dr. Thomas Kraft reinforces the management of Resuscitec GmbH
Recent Nature publication: Cellular recovery after prolonged warm ischaemia of the whole body
CARL-induced changes of the serum proteome
A recent publication in the Journal of Translational Medicine in May 2022 describes significant changes in serum protein composition after resuscitation using controlled extracorporeal circulation in pigs.
Current publication on the benefit of the CARL Therapy
The Journal of Clinical Medicine recently published an article describing the benefits of adapted perfusion and defibrillation strategies in the setting of CARL Therapy.
Letter to the editor: Important factors regarding the analysis of extracorporeal blood flow in extracorporeal cardiopulmonary resuscitation.
INVITED EXPERT OPINION IN THE JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY (JTCVS)
An Invited Expert Opinion has been published in the Journal of Thoracic and Cardiovascular Surgery (JTCVS) on the use of cardiac surgical techniques to improve outcomes of cardiopulmonary resuscitation after cardiovascular arrest.
For more information on CARL Therapy, please visit: Therapy (resuscitec.de)
Thanks to CARL – Larger time frame for successful resuscitation in cardiac arrest (text: German language)
The CARL Therapy developed by researchers of
The Medical Center – University of Freiburg and the mobile CARL System of Resuscitec GmbH provide a larger time window for the treatment of patients requiring resuscitation. An article published in “Ärztezeitung” in August, 2021 describes the therapeutic factors that are crucial for successful resuscitation even after prolonged cardiac arrest.
‘Originally it was not planned to treat Covid patients at all’ (text: German language)
Interview with Prof. Dr.-Ing. Christoph Benk and Jörg Ronde, Managing Directors of Resuscitec GmbH in the VentureCapital Magazin
New method of resuscitation: unharmed despite one-and-a-half hours of cardiac arrest (text: German language)
Just ten percent of those affected survive a cardiac arrest that happens outside a hospital – and only some of them without sequelae. A new method might change this. The ‘Neue Züricher Zeitung’ has published an article about CARL.
Imagefilm Resuscitec GmbH
The CARL system and its application possibilities
Another young life was saved – thanks to CARL.
A 36-year-old woman suffered a prolonged cardiac arrest lasting over one and a half hours. Only the use of CARL. enabled a successful resuscitation. The TV station SWR tells her story with CARL. in the following video (minute 8:30).
CARL product video
Abstract of the publication „Brain vulnerability and viability after ischemia” from the journal Nature Review Neuroscience
Professor Dr. Dr. h. c. Friedhelm Beyersdorf about the scientific basis of the CARL Therapy